By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoCellular Therapeutics, Ltd 



Los Angeles  California    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
ImmunoCellular Therapeutics, Ltd (IMUC) Chooses PharmaCell As Contract Manufacturing Partner For Its Phase III Program In Europe 3/20/2015 10:09:27 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Manufacturing Agreement With Pharmacell B.V. For European Production Of ICT-107 For Phase 3 Registration Trial 3/19/2015 6:31:59 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Fourth Quarter And Full Year 2014 Financial Results 3/10/2015 7:50:39 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At ROTH Conference On March 10th 3/3/2015 9:06:10 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Report 2014 Financial Results On March 9, 2015; A Business Update Conference Call And Webcast Is Scheduled For March 12, 2015 3/2/2015 8:12:01 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Strengthens Executive Management Team With Appointment Of Dr. Steven Swanson To Lead Stem-To-T-Cell Program 2/19/2015 9:03:59 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Pricing Of A Public Offering Of Common Stock And Warrants 2/12/2015 6:53:53 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 9, 2015 1/28/2015 10:54:03 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Issuance Of Key Patent For ICT-107 Cancer Vaccine 12/17/2014 8:01:31 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014 8:51:15 AM
12345678910...
//-->